338 related articles for article (PubMed ID: 14708469)
1. [Mechanism of inhibition OF COX-2 and COX-3 in gastrointestinal damage induced by NSAID in rats ].
Laudanno OM; San Miguel P; Aramberry LJ; Cesolari JA
Acta Gastroenterol Latinoam; 2003; 33(4):183-5. PubMed ID: 14708469
[TBL] [Abstract][Full Text] [Related]
2. COX-2-selective inhibitors (COXIBs): gastrointestinal safety.
Pronai L; Hritz I; Molnar B; Herszenyi L; Tulassay Z
Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):23-30. PubMed ID: 14552701
[TBL] [Abstract][Full Text] [Related]
3. New directions in cyclooxygenase research and their implications for NSAID-gastropathy.
Flower RJ
Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():23-7. PubMed ID: 9032578
[TBL] [Abstract][Full Text] [Related]
4. Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events.
Tanaka A; Hase S; Miyazawa T; Ohno R; Takeuchi K
J Pharmacol Exp Ther; 2002 Dec; 303(3):1248-54. PubMed ID: 12438549
[TBL] [Abstract][Full Text] [Related]
5. New NSAIDs and gastroduodenal damage.
Folco GC
Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():28-9. PubMed ID: 9032579
[TBL] [Abstract][Full Text] [Related]
6. [Selective COX-2 non-steroidal anti-inflammatory agents and gastrointestinal toxicity].
Zaragoza A; Llorente MJ; García MM; Ramírez JJ; Lloret G; Machancoses A
Rev Esp Enferm Dig; 2001 Dec; 93(12):819-20. PubMed ID: 11995364
[No Abstract] [Full Text] [Related]
7. Role of direct cytotoxic effects of NSAIDs in the induction of gastric lesions.
Tomisato W; Tsutsumi S; Hoshino T; Hwang HJ; Mio M; Tsuchiya T; Mizushima T
Biochem Pharmacol; 2004 Feb; 67(3):575-85. PubMed ID: 15037209
[TBL] [Abstract][Full Text] [Related]
8. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs.
Gerstenfeld LC; Thiede M; Seibert K; Mielke C; Phippard D; Svagr B; Cullinane D; Einhorn TA
J Orthop Res; 2003 Jul; 21(4):670-5. PubMed ID: 12798067
[TBL] [Abstract][Full Text] [Related]
9. [COX-2 specific inhibitors: are NSAIDs and the stomach become reconcilied?].
Bannwarth B
Gastroenterol Clin Biol; 2001 Apr; 25(4 Suppl):B79-84. PubMed ID: 11449148
[No Abstract] [Full Text] [Related]
10. Effects of cyclooxygenase inhibition on the gastrointestinal tract.
Radi ZA; Khan NK
Exp Toxicol Pathol; 2006 Nov; 58(2-3):163-73. PubMed ID: 16859903
[TBL] [Abstract][Full Text] [Related]
11. [Non-steroidal anti-inflammatory drugs and cyclooxygenase-2 selectivity in gastroenterology].
Ledro Cano D; Gómez Rodríguez BJ; Torres Domínguez Y; Hergueta Delgado P; Herrerías Esteban JM; Herrerías Gutiérrez JM
Rev Esp Enferm Dig; 1999 Apr; 91(4):305-9. PubMed ID: 10348929
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 inhibitors: promise or peril?
Mengle-Gaw LJ; Schwartz BD
Mediators Inflamm; 2002 Oct; 11(5):275-86. PubMed ID: 12467519
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase and nitric oxide systems in the gut as therapeutic targets for safer anti-inflammatory drugs.
Whittle BJ
Curr Opin Pharmacol; 2004 Dec; 4(6):538-45. PubMed ID: 15525540
[TBL] [Abstract][Full Text] [Related]
14. Safety of anti-inflammatory treatment--new ways of thinking.
Brune K
Rheumatology (Oxford); 2004 Feb; 43 Suppl 1():i16-20. PubMed ID: 14752171
[TBL] [Abstract][Full Text] [Related]
15. [Questions to Professor Jean-François Bretagne].
Bretagne JF
Gastroenterol Clin Biol; 2003 May; 27(5):518-21. PubMed ID: 12843914
[No Abstract] [Full Text] [Related]
16. Relationship between cyclooxygenase 1 and 2 selective inhibitors and fetal development when administered to rats and rabbits during the sensitive periods for heart development and midline closure.
Cappon GD; Cook JC; Hurtt ME
Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):47-56. PubMed ID: 12852483
[TBL] [Abstract][Full Text] [Related]
17. Rofecoxib produces intestinal but not gastric damage in the presence of a low dose of indomethacin in rats.
Yokota A; Taniguchi M; Takahira Y; Tanaka A; Takeuchi K
J Pharmacol Exp Ther; 2005 Jul; 314(1):302-9. PubMed ID: 15831440
[TBL] [Abstract][Full Text] [Related]
18. COX 2 inhibition and bowel strictures.
Maiden LP; Bjarnason I
Gut; 2004 Jul; 53(7):1057-8. PubMed ID: 15194667
[No Abstract] [Full Text] [Related]
19. [In vivo selectivity of nonsteroidal anti-inflammatory drugs on COX-1-COX-2 and gastrointestinal ulcers, in rats].
Laudanno OM; Cesolari JA; Esnarriaga J; Flaherty P; Vada J; Guastalli G; San Miguel P; Bedini OA
Acta Gastroenterol Latinoam; 1998; 28(3):249-55. PubMed ID: 9773153
[TBL] [Abstract][Full Text] [Related]
20. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
Price-Forbes AN; Callaghan R; Allen ME; Rowe IF
Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
